← All Biocardia, INC filings

Biocardia, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
BCDA
Biocardia, INC
DEF: BioCardia Seeks Shareholder Approval for Equity Plan Extension, Director Elections
BioCardia, Inc. announced its 2025 Annual Meeting of Stockholders will address the election of three Class III directors, an extension and amendment of its 2016 Equity Incentive Plan, and the ratification of its independent auditor.
NASDAQ
BCDA
Biocardia, INC
DEF 14A: BioCardia Seeks Stockholder Approval for Reverse Stock Split to Regain Nasdaq Compliance
BioCardia is asking stockholders to approve a reverse stock split and other corporate governance matters at its upcoming annual meeting to maintain its Nasdaq listing and for other corporate purposes.